Opportunity Information: Apply for RFA AG 23 012

This NIH grant opportunity (RFA-AG-23-012) is an R01 research solicitation focused on aging biology, specifically on how different "hallmarks of aging" influence one another through inter-organelle communication. The central idea is that aging is not driven by isolated cellular problems, but by networks of interacting processes, and a key way those processes may connect is through signaling and material exchange between organelles such as mitochondria, lysosomes, the endoplasmic reticulum, nucleus, peroxisomes, and related cellular compartments. The FOA is looking for innovative, mechanistic studies that can identify and characterize these cross-organelle pathways and then use that knowledge as a platform to understand how multiple hallmarks of aging become linked, reinforced, or modulated over time.

The scientific emphasis is on mechanistic approaches rather than descriptive observations. In practical terms, proposed projects are expected to go beyond simply showing that two organelles change with age. Competitive applications would typically aim to map the directionality and causality of communication (what signal is sent, from which organelle to which target, under what conditions), define the molecular players involved (proteins, lipids, metabolites, ions, nucleic acids, contact-site machinery, vesicular trafficking components, stress response pathways), and connect those communication routes to interactions among aging hallmarks. While the FOA text provided does not list specific hallmarks, the broader "hallmarks of aging" framework commonly includes processes such as genomic instability, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, dysregulated nutrient sensing, cellular senescence, stem cell exhaustion, altered intercellular communication, telomere attrition, and chronic inflammation. The program goal here is to use inter-organelle communication as the lens to interrogate how these types of processes intersect rather than treating them as separate, parallel tracks.

Administratively, this is a discretionary federal grant under the NIH, with the activity category in health research and the CFDA number listed as 93.866. The funding instrument is an R01, and the FOA explicitly states "Clinical Trial Not Allowed," meaning the supported work must be non-clinical-trial research. That typically allows a wide range of basic, translational, and preclinical studies, including cell-based systems, animal models, and human biospecimens or data analyses, as long as the study does not meet NIH’s definition of a clinical trial (for example, prospectively assigning human participants to an intervention to evaluate health-related outcomes).

The opportunity is broadly open to many types of applicants. Eligible applicants include standard U.S. public entities (state, county, city/township governments, special districts), independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, and a range of nonprofit organizations (both 501(c)(3) and non-501(c)(3) organizations, other than higher education institutions). It also allows applications from for-profit organizations (other than small businesses) and small businesses, as well as Native American tribal governments (federally recognized) and Native American tribal organizations (other than federally recognized tribal governments), public housing authorities/Indian housing authorities, and other applicant types captured under "Others." The FOA also highlights additional eligible groups and institution types, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations), indicating an intent to encourage wide participation across institutional settings and geographies.

In terms of timing and scale, the source data lists an original closing date of 2022-10-11 and an award ceiling of $250,000 (as provided in the record). The expected number of awards is not specified in the excerpt. Taken together, the FOA is best read as a targeted call for rigorous, hypothesis-driven research that uses organelle-to-organelle communication as a unifying mechanistic framework to explain how aging-related cellular processes connect, amplify each other, or potentially create intervention points that could alter trajectories of aging biology without conducting clinical trials.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Inter-Organelle Communication as a Platform to Interrogate the Interactions of Hallmarks of Aging (R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2022-02-25.
  • Applicants must submit their applications by 2022-10-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $250,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AG 23 012

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Bureau of Land Management Nevada Rangeland Resource Management

Previous opportunity: Bureau of Land Management Headquarters (HQ) Threatened and Endangered Species

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AG 23 012

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AG 23 012) also looked into and applied for these:

Funding Opportunity
Mapping Interconnectivity Among Hallmarks of Aging under Lifespan Modifications (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 013

Funding Number: RFA AG 23 013
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Noncoding RNAs in Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 010

Funding Number: RFA AG 23 010
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Noncoding RNAs in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed) Apply for RFA AG 23 011

Funding Number: RFA AG 23 011
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) Apply for PAR 22 128

Funding Number: PAR 22 128
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional) Apply for PAR 22 122

Funding Number: PAR 22 122
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,000,000
The Role of Dentistry in the Prevention of Opioid Drug Misuse and Abuse (UG3/UH3 Clinical Trial Optional) Apply for RFA DE 23 010

Funding Number: RFA DE 23 010
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) Apply for PAR 22 119

Funding Number: PAR 22 119
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R21 Clinical Trial Not Allowed) Apply for RFA DE 23 003

Funding Number: RFA DE 23 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R01 Clinical Trial Not Allowed) Apply for RFA DE 23 002

Funding Number: RFA DE 23 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional) Apply for PAR 22 107

Funding Number: PAR 22 107
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed) Apply for RFA OD 22 003

Funding Number: RFA OD 22 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,800,000
NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) Apply for PAR 22 135

Funding Number: PAR 22 135
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional) Apply for RFA OD 22 004

Funding Number: RFA OD 22 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $4,000,000
Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 22 022

Funding Number: RFA AI 22 022
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed) Apply for PAR 22 118

Funding Number: PAR 22 118
Agency: National Institutes of Health
Category: Health
Funding Amount: $230,000
Emergency Awards: Biocontainment Facility Improvements and Building System Upgrades to Support Pandemic Preparedness (G20 Clinical Trial Not Allowed) Apply for RFA AI 22 019

Funding Number: RFA AI 22 019
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) Apply for PAR 22 104

Funding Number: PAR 22 104
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
International Bioethics Research Training Program (D43 Clinical Trial Optional) Apply for PAR 22 116

Funding Number: PAR 22 116
Agency: National Institutes of Health
Category: Health
Funding Amount: $230,000
NIA Program Project Applications (P01 Clinical Trial Optional) Apply for PAR 22 130

Funding Number: PAR 22 130
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Addressing Mental Health Disparities Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01 Clinical Trial Not Allowed) Apply for RFA MH 22 200

Funding Number: RFA MH 22 200
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 23 012", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: